BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

28888

544319

SENORES

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SENORES PHARMACEUTICALS L performance

Today’s low

Today’s high

₹ 500.60 ₹ 517.00
₹ 506.20

52 week low

52 week high

₹ 435.25 ₹ 665.00
₹ 506.20

Open Price

₹ 510.00

Prev. Close

₹ 509.95

Volume (Shares)

211861.00

Total traded value

₹ 1072.44

Upper Circuit

₹ 611.90

Lower Circuit

₹ 408.00

info

SENORES PHARMACEUTICALS L Share Price Update

As of the latest trading session, SENORES PHARMACEUTICALS L share price is currently at ₹ 506.2, which is down by ₹ -3.75 from its previous closing. Today, the stock has fluctuated between ₹ 500.60 and ₹ 517.00. Over the past year, SENORES PHARMACEUTICALS L has achieved a return of 0.00 %. In the last month alone, the return has been -10.24 %. Read More...

SENORES PHARMACEUTICALS L fundamentals


  • Market cap (Cr)

    1,544.14

  • P/E Ratio (TTM)

    2,813.61

  • Beta

    2.10

  • Book Value / share

    159.10

  • Return on equity

    0.78%

  • EPS (TTM)

    0.18

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.07

info icon alternate text
  • Market cap (Cr)

    1,541.24

  • P/E Ratio (TTM)

    2,813.61

  • Beta

    1.97

  • Book Value / share

    159.10

  • Return on equity

    0.78%

  • EPS (TTM)

    0.18

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.07

info icon alternate text

SENORES PHARMACEUTICALS L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 9.59
Operating Expense 15.46
Net Profit 1.07
Net Profit Margin (%) 11.15
Earnings Per Share (EPS) 0.32
EBITDA 4.77
Effective Tax Rate (%) 18.93
Particulars MAR 2024 (Values in Cr)
Revenue 9.45
Operating Expense 0.00
Net Profit 0.34
Net Profit Margin (%) 3.59
Earnings Per Share (EPS) 0.11
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 8.91
Operating Expense 10.57
Net Profit 0.20
Net Profit Margin (%) 2.24
Earnings Per Share (EPS) 0.08
EBITDA 1.62
Effective Tax Rate (%) 59.18
Particulars MAR 2024 (Values in Cr)
Revenue 34.01
Operating Expense 38.83
Net Profit 0.81
Net Profit Margin (%) 2.38
Earnings Per Share (EPS) 0.35
EBITDA 6.78
Effective Tax Rate (%) 60.09
Particulars MAR 2023 (Values in Cr)
Revenue 12.38
Operating Expense 17.23
Net Profit 1.20
Net Profit Margin (%) 9.69
Earnings Per Share (EPS) 1.26
EBITDA 5.01
Effective Tax Rate (%) 38.14
Particulars MAR 2022 (Values in Cr)
Revenue 15.85
Operating Expense 15.98
Net Profit 0.29
Net Profit Margin (%) 1.82
Earnings Per Share (EPS) 0.33
EBITDA 1.97
Effective Tax Rate (%) 67.77
Particulars MAR 2021 (Values in Cr)
Revenue 7.91
Operating Expense 7.66
Net Profit 0.84
Net Profit Margin (%) 10.61
Earnings Per Share (EPS) 2.20
EBITDA 1.17
Effective Tax Rate (%) -109.99
Particulars MAR 2024 (Values in Cr)
Book Value / Share 66.96
ROE % 26.19
ROCE % 12.04
Total Debt to Total Equity 1.28
EBITDA Margin 20.70
Particulars MAR 2023 (Values in Cr)
Book Value / Share 46.36
ROE % 20.54
ROCE % 18.24
Total Debt to Total Equity 0.94
EBITDA Margin 46.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share 41.86
ROE % 2.71
ROCE % 3.33
Total Debt to Total Equity 0.40
EBITDA Margin 17.08
Particulars MAR 2024 (Values in Cr)
Book Value / Share 55.11
ROE % 0.78
ROCE % 2.56
Total Debt to Total Equity 0.76
EBITDA Margin 19.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share 39.66
ROE % 3.30
ROCE % 5.44
Total Debt to Total Equity 1.06
EBITDA Margin 40.47
Particulars MAR 2022 (Values in Cr)
Book Value / Share 38.54
ROE % 3.15
ROCE % 4.51
Total Debt to Total Equity 0.43
EBITDA Margin 15.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 24.91
ROE % 8.87
ROCE % 4.55
Total Debt to Total Equity 0.39
EBITDA Margin 14.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.05
Total Assets 621.88
Total Liabilities 621.88
Total Equity 231.71
Share Outstanding 30504615
Price to Book Ratio 0.00
Return on Assets (%) 5.05
Return on Capital (%) 6.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 131.05
Total Liabilities 131.05
Total Equity 45.49
Share Outstanding 9815000
Price to Book Ratio 0.00
Return on Assets (%) 6.43
Return on Capital (%) 7.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.21
Total Assets 59.15
Total Liabilities 59.15
Total Equity 36.59
Share Outstanding 9815000
Price to Book Ratio 0.00
Return on Assets (%) 1.67
Return on Capital (%) 1.95
Particulars MAR 2024 (Values in Cr)
Net Income 24.94
Cash from Operations -11.86
Cash from Investing -54.65
Cash from Financing 86.98
Net change in Cash 12.45
Free Cash Flow 39.96
Particulars MAR 2023 (Values in Cr)
Net Income 12.43
Cash from Operations 0.37
Cash from Investing -48.28
Cash from Financing 46.25
Net change in Cash -3.11
Free Cash Flow 47.65
Particulars MAR 2022 (Values in Cr)
Net Income 1.14
Cash from Operations -10.30
Cash from Investing -24.44
Cash from Financing 36.46
Net change in Cash 1.57
Free Cash Flow 0.37
Particulars MAR 2024 (Values in Cr)
Net Income 2.03
Cash from Operations -55.87
Cash from Investing -13.50
Cash from Financing 86.67
Net change in Cash 10.34
Free Cash Flow -36.61
Particulars MAR 2023 (Values in Cr)
Net Income 2.58
Cash from Operations -47.31
Cash from Investing 1.07
Cash from Financing 45.33
Net change in Cash -1.37
Free Cash Flow -46.96
Particulars MAR 2022 (Values in Cr)
Net Income 0.83
Cash from Operations -23.91
Cash from Investing -10.05
Cash from Financing 33.87
Net change in Cash -0.23
Free Cash Flow -23.43
Particulars MAR 2021 (Values in Cr)
Net Income 0.40
Cash from Operations -2.85
Cash from Investing -4.37
Cash from Financing 8.49
Net change in Cash 1.25
Free Cash Flow -0.06
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

SENORES PHARMACEUTICALS L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
506.20 -0.73 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 515.30
  • 26 Days 541.70
  • 10 Days 524.50
  • 50 Days 546.30
  • 12 Days 527.60
  • 100 Days 546.50
  • 20 Days 537.20
  • 200 Days 546.50
512.15 PIVOT

First Support

503.45

First Resistance

518.65

Second Support

496.95

Second Resistance

527.35

Third Support

488.25

Third Resistance

533.85

RSI

37.36

ADX

33.48

MACD

-14.11

Williams % R

-84.07

Commodity Channel Index (CCI)

-99.71

Date

2025-04-30

Week

95165.00

Same Day

90550.00

Month

155494.00

1 Year

2.11

3 Year

2.11

Over 1 Month

-10.24%

down

Over 1 Year

0.00%

down

Over 3 Months

-6.37%

down

Over 3 Years

0.00%

down

Over 6 Months

-9.12%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

SENORES PHARMACEUTICALS L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
40.4%
Promoter Holdings
45.77%
FII
4.16%
DII
9.65%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Swapnil Jatin Shah 3553531.0 (7.72%) Shareholding of Promoter and Promoter Group
Ashokbhai Vijaysinh Barot 3427780.0 (7.44%) Shareholding of Promoter and Promoter Group
Remus Pharmaceuticals Limited 3261744.0 (7.08%) Shareholding of Promoter and Promoter Group
Renosen Pharmaceuticals Private Limited 2698219.0 (5.86%) Shareholding of Promoter and Promoter Group
Anar Swapnil Shah 2294500.0 (4.98%) Shareholding of Promoter and Promoter Group
Aviraj Overseas Llc 1895190.0 (4.12%) Shareholding of Promoter and Promoter Group
Aditya Birla Sun Life Insurance Company Limited 1707428.0 (3.71%) Public Shareholding
Sangeeta Mukur Barot 1042955.0 (2.26%) Shareholding of Promoter and Promoter Group
Manoj Prakash Sanghvi 866984.0 (1.88%) Public Shareholding
Astorne Capital Vcc - Arven 844763.0 (1.83%) Public Shareholding
Ratnamani Marketing Private Limited 838095.0 (1.82%) Public Shareholding
Aviraj Group Llc 684750.0 (1.49%) Shareholding of Promoter and Promoter Group
Jayanti Mishrimal Sanghvi 666663.0 (1.45%) Public Shareholding
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) Fund 640883.0 (1.39%) Public Shareholding
Jigar Prakash Sanghvi 549523.0 (1.19%) Public Shareholding
Mahindra Manulife Large & Mid Cap Fund 509162.0 (1.11%) Public Shareholding
Sanghavi Pavankumar Mishrimalji Huf 507936.0 (1.1%) Public Shareholding
Espee Therapeutics Llp 495000.0 (1.07%) Shareholding of Promoter and Promoter Group
Jitendra Babulal Sanghvi 488516.0 (1.06%) Shareholding of Promoter and Promoter Group
Prakash Mishrimal Sanghvi 476190.0 (1.03%) Public Shareholding
Mukur Yogeshkumar Barot 456825.0 (0.99%) Shareholding of Promoter and Promoter Group
Dhananjay Ashokkumar Barot 330000.0 (0.72%) Shareholding of Promoter and Promoter Group
Shantaben Babulal Sanghvi 328569.0 (0.71%) Shareholding of Promoter and Promoter Group
Hemant Ishwarlal Modi 62000.0 (0.13%) Shareholding of Promoter and Promoter Group
Jatin Siddharthbhai Shah 30000.0 (0.07%) Shareholding of Promoter and Promoter Group
Pinky Jatin Shah 30500.0 (0.07%) Shareholding of Promoter and Promoter Group
Suhana Ventures Llc 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Remus Pharmaceuticals Llc 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Psyllium Labs Llc 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Espee Pharma Canada Llc 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Espee Pharma Uk Ltd 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aone Investments Management Llc 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ami Hemantbhai Modi 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Nirmala Brahmbhatt 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sonal H Rao 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Vasantiben V Brahmbhatt 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ssas Family Trust 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Svar Family Trust 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Swapnil Shah Family Trust 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Esdee Enterprise 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Salvino Biosciences Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Espee Drugs & Finechem Co. 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Gliesse Pharmaceuticals Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Healthy Life Nutraceuticals Llp 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Espee Lifesciences Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Espee International Finechempharma Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Relius Lifesciences Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aelius Projects Llp 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Di Cal Pharma Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ashwamegh Minerals 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aps International 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aviraj Charitable Foundation 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Tierra Fertilizer Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aviraj Ventures Llp 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Swapnil J Shah Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Jatin Siddharthabhai Shah Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Modi Hemantbhai Ishwarlal Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ashokkumar Vijaysinh Barot Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sonal Hemant Modi 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Suhana Swapnil Shah 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Vihaan Swapnil Shah 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Darshil Jatinbhai Shah 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shailesh Brahmbhatt 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Hemagauri Ashokkumar Barot 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Viraj Ashokkumar Barot 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Parul Barot 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Bhavna Barot 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rajendra Brahmbhatt 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

SENORES PHARMACEUTICALS L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SENORES PHARMACEUTICALS L Share Price

Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre. Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company.

Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms. The Regulated Markets business is focused on Regulated Markets of US and Canada. The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs. Further, it develop and manufacture pharmaceutical products across various therapeutic areas for Emerging Markets, having a presence across 43 countries. The Company operate a Critical Care Injectables Business, supplying critical care injectables to hospitals across India through distributors, and manufacture APIs for the domestic market and SAARC countries.

In 2021, the Company incorporated a wholly owned subsidiary, Senores Pharmaceuticals Inc in the US. It then entered the new segment of API by acquiring Ratnagene Lifescience Private Limited. The Company started domestic business with the launch of the Critical Care Injectables Business in 2022.

The Company further acquired majority stake in Havix Group Inc., making it a subsidiary of the Company in 2023. It consolidated presence in emerging markets by acquiring shares in Ratnatris Pharmaceuticals Private Limited, making it a Subsidiary of the Company in 2023. The Company has launched CMO product in the US with Jubilant Cadista Pharmaceuticals Inc., in 2024.

The Company is planning to raise money from public through IPO by issue and allotment of 2,700,000 Equity Shares through Offer for Sale and Rs 500 Crores equity funds through Fresh Issue.

Parent organization Indian Private
NSE symbol SENORES
Founded 2017
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Senores Pharmaceuticals Ltd?

Answer Field

The share price of Senores Pharmaceuticals Ltd for NSE is ₹ 506.2 and for BSE is ₹ 505.25.

What is the Market Cap of Senores Pharmaceuticals Ltd?

Answer Field

The market cap of Senores Pharmaceuticals Ltd for NSE is ₹ 15,44.14 Cr. and for BSE is ₹ 15,41.24 Cr. as of now.

What is the 52 Week High and Low of Senores Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Senores Pharmaceuticals Ltd for NSE is ₹ 665.00 and ₹ 435.25 and for BSE is ₹ 664.00 and ₹ 440.00.

How to Buy Senores Pharmaceuticals Ltd share?

Answer Field

You can trade in Senores Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Senores Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the Current Share Price of Senores Pharmaceuticals Ltd?

Answer Field

Senores Pharmaceuticals Ltd share price is for NSE ₹ 506.2 & for BSE ₹ 505.25 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Senores Pharmaceuticals Ltd Share?

Answer Field

The market cap of Senores Pharmaceuticals Ltd for NSE ₹ 15,44.14 & for BSE ₹ 15,41.24 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Senores Pharmaceuticals Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Senores Pharmaceuticals Ltd share is 2813.61.

What is the PB ratio of Senores Pharmaceuticals Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Senores Pharmaceuticals Ltd share is 159.10.

How to Buy Senores Pharmaceuticals Ltd Share?

Answer Field

You can trade in Senores Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Senores Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Senores Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Senores Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|